ALMU insider files Form 144/A to sell $2.83M of stock via Oppenheimer

Rhea-AI Filing Summary

Aeluma, Inc. (ALMU) filing a Form 144/A notifies the market of a proposed sale of 150,000 common shares by an insider through Oppenheimer & Co., with an aggregate market value of $2,827,312.50. The shares represent part of a holding of 15,795,467 shares outstanding and the approximate sale date is 08/14/2025 on NASDAQ. The securities were originally acquired in a private placement on 10/27/2020 from the issuer, with payment completed on that date. The filer reports no shares sold in the past three months and includes the standard representation that they are unaware of any undisclosed material adverse information about the issuer.

Positive

• Full disclosure of sale details: quantity (150,000 shares), aggregate value ($2,827,312.50), broker (Oppenheimer & Co.), and proposed sale date (08/14/2025).
• Clear acquisition history: shares were acquired in a private placement on 10/27/2020 with payment completed on that date.

Negative

• Increase in shares available for sale: the proposed 150,000-share sale equals 0.95% of the reported 15,795,467 shares outstanding, which could modestly increase selling pressure if executed.
• No identity disclosed in provided content: the text does not specify the name of the person for whose account the securities are to be sold in the excerpt provided.

Insights

Securities Analyst

TL;DR Routine insider notice: 150,000 shares planned for sale, acquired in a 2020 private placement, scheduled via broker on NASDAQ.

The Form 144/A is a disclosure of an intended Rule 144 sale by a person who acquired the shares in a private placement on 10/27/2020. The filer identifies Oppenheimer & Co. as the broker and sets an approximate sale date of 08/14/2025. The filing confirms no related sales in the prior three months and includes the usual attestation about material non-public information. For investors, this is a standard compliance notice enabling an insider sale; it provides timing, quantity, source and broker but no information about purpose of sale or insider identity in the text provided.

Corporate Governance Expert

TL;DR Compliance-focused filing that documents an insider's planned disposition under Rule 144; no governance red flags disclosed.

The document documents required procedural details: class of security, acquisition date and nature (private placement), broker, proposed sale date, and outstanding share count. It asserts the signer has no undisclosed material adverse information. The filing lacks additional governance signals such as plan adoption date under Rule 10b5-1 or any recent related-party transactions. Based on the content provided, this is a routine regulatory disclosure rather than a governance event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co Inc 85 Broad St New York NY 10004	150000	2827312.50	15795467	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2020	Private Placement	Issuer			150000	10/27/2020	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Aeluma's (ALMU) Form 144/A disclose?

The filing discloses a proposed sale of 150,000 common shares via Oppenheimer & Co. for an aggregate market value of $2,827,312.50, with an approximate sale date of 08/14/2025 on NASDAQ.

When and how were the shares being sold acquired according to the filing?

The shares were acquired in a private placement on 10/27/2020, purchased from the issuer with payment completed on that date.

How large is the proposed sale relative to Aeluma's outstanding shares?

The proposed sale of 150,000 shares is out of 15,795,467 shares outstanding, approximately 0.95% of the outstanding share count.

Did the filer report any sales in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Which broker will handle the proposed sale listed in the Form 144/A?

The broker named in the filing is Oppenheimer & Co. Inc, located at 85 Broad St, New York, NY 10004.